FDA Adverse Event Injury Summary report: N

CORAIL2 STD SIZE 12

MDR report key: 3092597 · Received May 3, 2013

Report

Report Number
1818910-2013-05442
Event Type
Injury
Date Received
May 3, 2013
Date of Event
April 19, 2011
Report Date
February 16, 2012
Manufacturer
DEPUY INTERNATIONAL
Product Code
KWA
PMA / PMN Number
K042992
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

EXAMINATION OF THE REPORTED DEVICES WAS NOT POSSIBLE AS THEY WERE NOT RETURNED. A SEARCH OF THE COMPLAINTS DATABASES AGAINST THE FEMORAL STEM PRODUCT/LOT CODE COMBINATION FINDS NO OTHER REPORTS SINCE ITS RELEASE TO DISTRIBUTION. THE INVESTIGATION CAN DRAW NO CONCLUSIONS REGARDING THE REPORTED CORROSION. IT IS KNOWN THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Description of Event or Problem · 1

PATIENT WAS REVISED TO ADDRESS PAIN. BLOODY AND METALLIC FLUID WAS COLLECTED FROM THE JOINT. SOFT TISSUE WAS STAINED THROUGHOUT THE JOINT. UPDATE A REVIEW OF MEDICAL RECORDS, CORROSION WAS NOTED INTEROPERATIVE ON THE TAPER. ALSO NOTED IN REVISION NOTES DURING THE IMPACTION OF THE CUP THERE WAS A SPLIT INTO THE SCIATIC NOTCH, HOWEVER A COMPETITORS DEVICE WAS USED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
194682 CORAIL2 STD SIZE 12 FEMORAL STEM HIP IMPLANT KWA DEPUY INTERNATIONAL 2753581

Patients

Seq Age Sex Outcome Treatment
1 75 YR Required Intervention